Thyroid Nodules study: Thyroid Artery Embolization
Official title Thyroid Artery Embolization for the Treatment of Compressive Goiters.
ClinicalTrials.gov ID: NCT07360587
What this study is testing
- What it's testing
- The study will see how well and how safely this technique, called thyroid artery embolization, reduces pressure symptoms from large thyroid nodules. It will also collect detailed imaging and follow‑up data to confirm earlier findings.
- Who it's for
- Adults with thyroid nodules that are too large or causing symptoms and who cannot or choose not to have standard treatments like surgery or radioactive iodine.
- What's involved
- Participants will receive the embolization procedure, which blocks blood flow to the nodule. They will have imaging tests before and after the procedure and regular follow‑up visits to monitor symptoms and side effects.
- Time commitment
- The study lasts about 12 months, with an initial procedure visit, a short recovery period, and several follow‑up appointments over the year.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND
- Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND
- TiRADS category 1, 2, 3 or 4 AND
- Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND
- Patient at least 18 years old.
You likely can't join if
- Comorbidities precluding endovascular procedure OR
- TiRADS category 5 OR
- Bethesda categories IV, V, VI on biopsy OR
- Refusal of the patient to participate OR
- Uncontrolled severe hyperthyroidism OR
- Minor patient.
The study team makes the final eligibility decision.
Where it is enrolling
- Sherbrooke, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sherbrooke, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.